M&A Deal Summary |
|
|---|---|
| Date | 2020-11-12 |
| Target | MyMD Pharmaceuticals |
| Sector | Life Science |
| Buyer(s) | Q/C Technologies |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2014 |
| Sector | Life Science |
| Employees | 6 |
Q/C Technologies is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control TNF-? and other pro-inflammatory cytokines. Q/C Technologies was founded in 2014 and is based in New York, United States.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Florida M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
